Send a Tweet
Most Popular Choices
Share on Facebook 15 Share on Twitter Printer Friendly Page More Sharing
General News    H2'ed 3/13/13

With Blockbuster Pills No Longer Selling, Pharma Turns to Injections

By       (Page 1 of 2 pages)   2 comments
Message Martha Rosenberg
Become a Fan
  (84 fans)

(Article changed on March 13, 2013 at 15:26)

(Article changed on March 13, 2013 at 13:41)

(Article changed on March 13, 2013 at 10:38)

It's no secret that the bloom has fallen off Pharma's rose. Blockbuster pills like Lipitor, Seroquel, Zyprexa, Singulair and Concerta have gone off patent with nothing in the pipeline to replace them. Medical journals like the Journal of the American Medical Association (JAMA) and New England Journal of Medicine (NEJM) are noticeably thinner without the Pharma ads that have leavened them for years. As ad revenues attenuate, WebMD, the voice of Pharma on the Web, is also withering on the vine and announced it would cut 250 positions in December.


As the blockbuster pill model breaks down, Pharma is pushing vaccines and injectable drugs which cost hundreds per dose, can sometimes be co-marketed through pharmacies and are not as susceptible to generic competition. Especially lucrative to Pharma are genetically modified biologic drugs that suppress the body's tumor necrosis factor (TNF). TNF-blockers, which cost around $20,000 a year, can be life saving for autoimmune diseases but life-threatening for diseases which do not warrant them! Nonetheless Pharma is marketing TNF-blockers for arthritis, back pain, skin and digestive disorders, to prevent bone thinning and even for asthma. Ka-ching.

Thanks, Big Pharma
Thanks, Big Pharma
(Image by Martha Rosenberg)
  Details   DMCA


Most of the TNF-blockers are linked to TB, cancers and super infections according to their labels because they suppress the immune system. One such drug, Xolair, was investigated by the FDA for links to heart attack and stroke and 77 people who took Xolair had life-threatening allergic responses in a year and a half, according to FDA reports. Still it is "recommended" for asthma by doctors who are consultants to Pharma. What?


This month, Xolair, marketed by Genentech and Novartis, was trumpeted in the New York Times for having a new possible use of treating patients with chronic hives or chronic idiopathic urticaria. If approved for the new indication, chronic idiopathic urticaria will likely became a major U.S. health problem to be advertised on TV like restless legs syndrome.


Some of the clinical tests to determine Xolair's safety were conducted at Vivra which was investigated twice by the FDA because of whistleblower reports. Trials of Xolair and at least seven other drugs were corrupted by protocol violations and outright fraud, according to a former clinical research subinvestigator who worked at the facility. Patients were pressured to participate in trials and not warned of the risks, patients' drug diaries were falsified and insurers were billed for services which were actually enriching the investigator running the trials. San Mateo, Calif.-based Vivra Asthma & Allergy was the nation's largest respiratory disease practice until a merger with Lakewood, Colo.-based Gambro in 1997 and with El Segundo, Calif.-based DaVita in 2005.


Other TNF blockers Pharma is pushing are Humira for back pain that ads now suggest might actually be an autoimmune disorder and Prolia to prevent osteoporosis.

Next Page  1  |  2

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Must Read 1   News 1   Interesting 1  
Rate It | View Ratings

Martha Rosenberg Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
   (Opens new browser window)

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

It's the Cymbalta Stupid

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too

To View Comments or Join the Conversation:

Tell A Friend